Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0NRUGI)
| ADC Name |
Palivizumab_msIgG2a Conjugate 3
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Palivizumab_msIgG2a Conjugate 3
Click to Show/Hide
|
|||||
| Organization |
MERSANA THERAPEUTICS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.7
|
|||||
| Antibody Name |
Palivizumab_msIgG2a
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||